Cargando…
Prognostic benefit of comprehensive genomic profiling in clinical practice remains uncertain
The overall survival of patients who received genomically matched therapy was not significantly longer than that of patients receiving treatment only other than genomically matched therapy in the breast invasive ductal carcinoma (A), colorectal adenocarcinoma (B), and pancreatic adenocarcinoma (C) c...
Autor principal: | Ikegami, Masachika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323084/ https://www.ncbi.nlm.nih.gov/pubmed/37121885 http://dx.doi.org/10.1111/cas.15826 |
Ejemplares similares
-
The role of nitrous oxide remains uncertain
por: Hirvioja, Jouni, et al.
Publicado: (2016) -
Epileptic seizure? Certainly uncertain
por: Heinrich, Sven P., et al.
Publicado: (2021) -
Recovery of assessed global fish stocks remains uncertain
por: Britten, Gregory L., et al.
Publicado: (2021) -
Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022) -
The rewarming benefit of anterior torso heat pad application in mildly hypothermic conscious adult trauma patients remains inconclusive
por: Ting, Joseph Yuk Sang
Publicado: (2012)